Dexamethasone-cyclophosphamide pulse therapy in pemphigus: A review of 72 cases

American Journal of Clinical Dermatology

Volumn 11, Issue 2, 2010, Pages 123-129

  Zivanovic, Dubravka ^a,b   Medenica, Ljiljana ^a,b   Tanasilovic, Srdjan ^a,b   Vesic, Sonja ^a,b   Skiljevic, Dusan ^a,b   Tomovic, Maja ^a,b   Nikolic, Milos M ^a,b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; PREDNISONE;

ADULT; AGED; AMENORRHEA; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPISTAXIS; ERYTHEMATOUS PEMPHIGUS; FEMALE; FLUSHING; HAIR LOSS; HEART ARREST; HEART INFARCTION; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOFLUORESCENCE TEST; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTIPLE CYCLE TREATMENT; MYALGIA; PARANEOPLASTIC PEMPHIGUS; PEMPHIGUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; RHABDOMYOLYSIS; SEPSIS; SIDE EFFECT; SKIN PIGMENTATION; TACHYCARDIA; THRUSH; TREATMENT OUTCOME; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ADULT; AGED; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PEMPHIGUS; PULSE THERAPY, DRUG; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77949392098     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11311150-000000000-00000     Document Type: Article

References (28)

1. Rosenberg FR, Sanders S, Nelson CT. Pemphigus: a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 1976; 112: 962-970
2. Pasricha JS, Gupta R. Pulse therapy with dexamethasone-cyclophosphamide in pemphigus. Indian J Dermatol Venereol Leprol 1984; 50: 199-203
3. Pasricha JS, Khaitan BK, Shantha Raman R, et al. Dexamethasonecyclophosphamide pulse therapy for pemphigus. Int J Dermatol 1995; 34: 875-882
4. Pasricha JS. Pulse therapy as a cure for autoimmune diseases. Indian J Dermatol Venereol Leprol 2003; 69: 323-328
5. Dogra A, Gupta S, Khurana S. Dexamethasone-cyclophosphamide pulse therapy in pemphigus: a five year retrospective study. Ind J Dermatol 2003; 48: 71-74
6. Kanwar AJ, Kaur S, Thami P. Long term efficacy of dexasmethasonecyclophosphamide pulse therapy in pemphigus. Dermatology 2002; 204: 228-231
7. Pasricha JS, Seetharam KA, Das U. Further studies on pemphigus patients treated with dexamethasone-cyclophosphamide pulse therapy for pemphigus. Indian J Dermatol Venereol Leprol 1989; 55: 98-104
8. Appelhans M, Bonsmann G, Orge C, et al. Dexamethasone-cyclophosphamide pulse therapy in bullous autoimune dermatoses. Hautarzt 1993; 44: 143-147
9. Toth GG, van der Meer JB, Jonkman MF. Dexamethasone pulse therapy in pemphigus. J Eur Acad Dermatol Venereol 2002; 16: 562-563
10. Pasricha JS, Das SS. Curative effect of dexamethasone-cyclophosphamide pulse therapy for the treatment of pemphigus vulgaris. Int J Dermatol 1992; 31: 875-877
11. Gupta R. Prolonged remission of pemphigus induced by dexamethasonecyclophosphamide pulse therapy. Indian J Dermatol Venereol Leprol 2007; 73: 121-122
12. Agarwal M, Walia R, Kochhar AM, et al. Pemphigus area and activity score (PAAS):anovel clinical scoring method for monitoringofpemphigus vulgaris patients. Int J Dermatol 1998; 37: 158-160
13. Micali G, Musumeci ML, Nasca MR. Epidemiologic analysis and clinical course of 84 consecutive cases of pemphigus in Eastern Sicily. Int J Dermatol 1998; 37: 197-200
14. Burge SM. Intraepidermal immunobullous diseases. In: Rook A, Wilkinson DS, Ebling FJG, et al., editors. Textbook of dermatology. 6th ed. Oxford: Blackwell Science, 1998: 1847-1864
15. Aberer W, Wolff-Schreiner EC, Stingl G, et al. Azathioprine in the treatment of pemphigus vulgaris: a long term follow up. J Am Acad Dermatol 1987; 16 (3 Pt 1): 527-533
16. Ljubojevic S, Lipozencic J, Brenner S, et al. Pemphigus vulgaris: a review of treatment over a 19-year period. J Eur Acad Dermatol Venereol 2002; 16: 599-603
17. Tsankov N, Vassileva S, Kamarashev J, et al. Epidemiology of pemphigus in Sofia, Bulgaria: a 16-year retrospective study (1980-1995). Int J Dermatol 2000; 39: 104-108
18. Mahajan VK, Sharma NL, Sharma RC, et al. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases. Int J Dermatol 2005; 44: 821-827
19. Hari P, Srivastava RN. Pulse cortiocosteroid therapy with methylprednisolone or dexamethasone. Indian J Pediatr 1998; 65: 557-560
20. Becker LR, Bastian BC, Wesselman U, et al. Paraneoplastic pemphigus treated with dexamethasone-cyclophosphamide pulse therapy. Eur J Dermatol 1998; 8: 551-553
21. Jain R, Kumar B. Immediate and delayed complications of dexamethasonecyclophosphamide pulse (DCP) therapy. J Dermatol 2003; 30: 713-718
22. Saoji VA. Premature ovarian failure due to cyclophosphamide: a report of four cases in dermatology practice. Indian J Dermatol Venereol Lerol 2008; 74: 128-132
23. Gokhale NR, Mahajan PM, Sule RR, et al. Treatment of pemphigus with intravenous pulse cyclophosphamide. Indian J Dermatol Venereol Leprol 2003; 69: 334-337
24. Momeni AZ, Iraji F, Aminjavaheri M, et al. The use of oral cyclophosphamide with dexamethasone pulse therapy in the treatment of pemphigus vulgaris. J Dermatolog Treat 2007; 18 (5): 275-278
25. Chryssomalis F, Dimitriades A, Chaidemenos GC, et al. Steroid-pulse therapy in pemphigus vulgaris, long term follow up. Int J Dermatol 1995; 34: 438-512
26. Pasricha JS, Thanzama J, Uttam Kumar K. Intermittent high dose dexamethasone-cyclophosphamide therapy for pemphigus. Br J Dermatol 1988; 119: 73-78
27. Coco TJ, Klasner AE. Drug-induced rhabdomyolysis. Curr Opin Pediatr 2006; 16: 206-210
28. Huilgol SC, Bhogal BS, Black MM. Immunofluorescence of the immunobullous disorders. Eur J Dermatol 1995; 5: 186-196